DR
Diana Romero
Honoured in the The Morning Science Hall of Fame for 1 article that made it into the paper. Published in Nature.
Articles · 1
- Sacituzumab tirumotecan–pembrolizumab has efficacy in PD-L1-negative NSCLC
Nature · Medicine · Nov 6, 2026 · Original ↗